SREBF1 and neoplasm: It has been reported that combining the siRNA interferes SREBP1 with docetaxel in a nano delivery system (PB@LC/D/siR) could inhibit tumor cells proliferation, migration, and invasion with high safety, deep tumor penetration, and decent bone protection at the tumor site.